Intestinal gluconeogenesis and glucose transport according to body fuel availability in rats.
Intestinal hexose absorption and gluconeogenesis have been studied in relation to refeeding after two different fasting phases: a long period of protein sparing during which energy expenditure is derived from lipid oxidation (phase II), and a later phase characterized by a rise in plasma corticosterone triggering protein catabolism (phase III). Such a switch in body fuel uses, leading to changes in body reserves and gluconeogenic precursors, could modulate intestinal gluconeogenesis and glucose transport. The gene and protein levels, and the cellular localization of the sodium-glucose cotransporter SGLT1, and of GLUT5 and GLUT2, as well as that of the key gluconeogenic enzymes phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (Glc6Pase) were measured. PEPCK and Glc6Pase activities were also determined. In phase III fasted rats, SGLT1 was up-regulated and intestinal glucose uptake rates were higher than in phase II fasted and fed rats. PEPCK and Glc6Pase mRNA, protein levels and activities also increased in phase III. GLUT5 and GLUT2 were down-regulated throughout the fast, but increased after refeeding, with GLUT2 recruited to the apical membrane. The increase in SGLT1 expression during phase III may allow glucose absorption at low concentrations as soon as food is available. Furthermore, an increased epithelial permeability due to fasting may induce a paracellular movement of glucose. In the absence of intestinal GLUT2 during fasting, Glc6Pase could be involved in glucose release to the bloodstream via membrane trafficking. Finally, refeeding triggered GLUT2 and GLUT5 synthesis and apical recruitment of GLUT2, to absorb larger amounts of hexoses.
Habold
Caroline
C
CNRS, CEPE, 23 rue Becquerel, F-67087 Strasbourg, cedex 2, France. caroline.habold@c-strasbourg.fr
Foltzer-Jourdainne
Charlotte
C
Le Maho
Yvon
Y
Lignot
Jean-Hervé
JH
Oudart
Hugues
H
D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D015152:Blotting, Northern; D015153:Blotting, Western; D004435:Eating / Q000502:physiology; D004734:Energy Metabolism / Q000502:physiology*; D015870:Gene Expression; D005943:Gluconeogenesis / Q000502:physiology*; D005947:Glucose / Q000378:metabolism*; D051273:Glucose Transporter Type 2; D051296:Glucose Transporter Type 5; D005952:Glucose-6-Phosphatase / Q000378:metabolism; D005990:Glycerol / Q000378:metabolism; D006601:Hexoses / Q000378:metabolism; D007150:Immunohistochemistry; D007408:Intestinal Absorption / Q000502:physiology; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000502:physiology*; D015227:Lipid Peroxidation / Q000502:physiology; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism; D009004:Monosaccharide Transport Proteins / Q000235:genetics / Q000378:metabolism; D019764:Phosphoenolpyruvate Carboxykinase (ATP) / Q000378:metabolism; D051381:Rats; D051269:Sodium-Glucose Transporter 1; D015431:Weight Loss / Q000502:physiology
D000596:Amino Acids; D051273:Glucose Transporter Type 2; D051296:Glucose Transporter Type 5; D006601:Hexoses; D008562:Membrane Glycoproteins; D009004:Monosaccharide Transport Proteins; C495676:Slc5a1 protein, rat; D051269:Sodium-Glucose Transporter 1; D005952:Glucose-6-Phosphatase; D019764:Phosphoenolpyruvate Carboxykinase (ATP); D005947:Glucose; D005990:Glycerol